Michael Rosen

441 total citations
13 papers, 333 citations indexed

About

Michael Rosen is a scholar working on Molecular Biology, Oncology and Management of Technology and Innovation. According to data from OpenAlex, Michael Rosen has authored 13 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Management of Technology and Innovation. Recurrent topics in Michael Rosen's work include Intellectual Property and Patents (3 papers), Cancer-related Molecular Pathways (3 papers) and CRISPR and Genetic Engineering (2 papers). Michael Rosen is often cited by papers focused on Intellectual Property and Patents (3 papers), Cancer-related Molecular Pathways (3 papers) and CRISPR and Genetic Engineering (2 papers). Michael Rosen collaborates with scholars based in United States, Germany and Argentina. Michael Rosen's co-authors include Linda S. Chan, Petar Vukasin, Robert W. Beart, Gary J. Anthone, Alvin I. Krasna, Prasanna Kumar, Andres Forero‐Torres, David Trent, Lowell L. Hart and Jonathan Greenberg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Critical Care Medicine.

In The Last Decade

Michael Rosen

12 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Rosen United States	7	192	142	55	46	44	13	333
Wentao Pan China	10	139 0.7×	191 1.3×	58 1.1×	41 0.9×	56 1.3×	31	346
Liangliang Dong China	10	63 0.3×	133 0.9×	30 0.5×	102 2.2×	14 0.3×	32	306
Rebecca Harris United Kingdom	5	132 0.7×	75 0.5×	17 0.3×	39 0.8×	93 2.1×	10	239
Pablo García‐Sanz Spain	11	62 0.3×	272 1.9×	83 1.5×	63 1.4×	31 0.7×	12	387
Yehuda E. Deutsch United States	8	103 0.5×	72 0.5×	52 0.9×	19 0.4×	44 1.0×	23	242
Tihana Rumboldt United States	8	58 0.3×	68 0.5×	43 0.8×	32 0.7×	129 2.9×	10	284
Nikolaos Ioannou United Kingdom	10	184 1.0×	95 0.7×	70 1.3×	65 1.4×	65 1.5×	22	302
Heinz-Josef Lenz United States	7	181 0.9×	144 1.0×	26 0.5×	33 0.7×	35 0.8×	9	294
Janet Graham United Kingdom	9	87 0.5×	171 1.2×	18 0.3×	88 1.9×	47 1.1×	24	346
Dianne Spillman United States	6	179 0.9×	144 1.0×	37 0.7×	131 2.8×	44 1.0×	8	387

Countries citing papers authored by Michael Rosen

Since Specialization

Citations

This map shows the geographic impact of Michael Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rosen more than expected).

Fields of papers citing papers by Michael Rosen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rosen. The network helps show where Michael Rosen may publish in the future.

Co-authorship network of co-authors of Michael Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rosen. A scholar is included among the top collaborators of Michael Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rosen. Michael Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Rosen, Michael, et al.. (2018). 993: ACUTE TIANEPTINE TRIPLE TOXICITY. Critical Care Medicine. 47(1). 475–475. 1 indexed citations

Forero, Andres, Johanna C. Bendell, Prasanna Kumar, et al.. (2017). First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors. Investigational New Drugs. 35(3). 298–306. 30 indexed citations

DiNardo, Courtney D., Joseph Rosenthal, Michael Andreeff, et al.. (2016). Phase 1 Dose Escalation Study of MDM2 Inhibitor DS-3032b in Patients with Hematological Malignancies - Preliminary Results. Blood. 128(22). 593–593. 29 indexed citations

Gounder, Mrinal M., Todd M. Bauer, Gary K. Schwartz, et al.. (2016). A phase 1 study of the MDM2 inhibitor DS-3032b in patients (pts) with advanced solid tumors and lymphomas.. Journal of Clinical Oncology. 34(15_suppl). 2581–2581. 22 indexed citations

Bauer, Todd M., David S. Hong, Neeta Somaiah, et al.. (2015). Abstract B27: A phase I dose escalation study of the MDM2 inhibitor DS-3032b in patients with advanced solid tumors and lymphomas. Molecular Cancer Therapeutics. 14(12_Supplement_2). B27–B27. 4 indexed citations

Rosen, Michael, et al.. (2013). Patenting Genes in a Post- Myriad World. Industrial Biotechnology. 9(4). 163–164. 1 indexed citations

Forero‐Torres, Andres, Jeffrey R. Infante, David Waterhouse, et al.. (2013). Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive patients with unresectable or metastatic pancreatic cancer. Cancer Medicine. 2(6). 925–932. 72 indexed citations

Rosen, Michael, et al.. (2009). Description proscription? Ariad v. Lilly decision to be reviewed by full court. Industrial Biotechnology. 5(3). 174–175.

Rosen, Michael, et al.. (2009). Ariad decision underlines importance of fully describing patented biotech inventions. Industrial Biotechnology. 5(2). 84–85. 1 indexed citations

10.

Rosen, Michael. (2005). A Qualified Defense: In Support of the Doctrine of Qualified Immunity in Excessive Force Cases, With Some Suggestions for its Improvement. Golden Gate University law review. 35(2). 2. 1 indexed citations

11.

Rosen, Michael, Linda S. Chan, Robert W. Beart, Petar Vukasin, & Gary J. Anthone. (1998). Follow-up of colorectal cancer. Diseases of the Colon & Rectum. 41(9). 1116–1126. 139 indexed citations

12.

Rosen, Michael, et al.. (1983). Effect of oxygen removal on hydrogen photoproduction in algae. Biotechnology and Bioengineering. 25(7). 1897–1904. 11 indexed citations

13.

Rosen, Michael & Alvin I. Krasna. (1980). LIMITING REACTIONS IN HYDROGEN PHOTOPRODUCTION BY CHLOROPLASTS AND HYDROGENASE. Photochemistry and Photobiology. 31(3). 259–265. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact